IRF5 and osteosarcoma: Roberts et al. studied the interferon regulatory factor 5 (IRF5) and found that its expression in osteosarcoma clinically correlates with prolonged survival and decreased secretion of tumor-derived extracellular vesicles (t-dEVs).